2m 2m 2m 2m 2m 2m 2m
Bioxytran (BIXT)
OTC
$0.02+$0.002 (+9.97%)
Price as of Sep 11, 2026- $2.7MMarket Cap
- -74.25%1-Year Change
- BiotechnologyIndustry
Bioxytran (BIXT)
$0.02+$0.002 (+9.97%)
BIXT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.02 | ||
Change | +$0.002 (+9.97%) | ||
Open | $0.02 | ||
High | $0.02 | ||
Low | $0.02 | ||
Previous Close | $0.02 | ||
Volume | 36,330 | ||
30-Day Average Volume | 135,193 | ||
1-Week Change | 10.42% | ||
1-Month Change | -6.61% | ||
1-Year Change | -74.25% | ||
3-Year Change | -86.38% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 114.7M | ||
Total Assets | $333,393.00 | ||
Market Cap | $2.7M | ||
Enterprise Value | $4.8M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$619,929.00 | ||
Free Cash Flow | -$349,773.00 | ||
EBIT | -$619,929.00 | ||
EBITDA | -$614,349.00 | ||
Net Working Capital | -$5.1M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -1 | ||
P/E | -2 | ||
PEG | -0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue